ARTV Artiva Biotherapeutics, Inc.
$10.22▼ -1.92%
Healthcare
Other
After hours
$10.15▼ -0.68%
Sep 11, 7:30 PM ET
Volume 228.4K
Avg Volume (10D) 278.7K
Key Metrics & Fundamentals
Market Cap
$499.66M
P/E Ratio
–
Div Yield
–%
52W Range
2.22 - 14.53
% vs 50 MA
-3.94%
% vs 200 MA
35.36%
RSI-14
38.4
MACD Histogram
-0.1900
Beta (1Y vs SPY)
2.09
Free Cash Flow
-$20.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$26.20M
COGS
–
Operating Exp
$26.89M
Operating Income
-$26.89M
EBIT
-$26.89M
Pretax Income
-$25.01M
Net Income
-$25.01M
EPS (Diluted)
-0.63
Price & Volume History
Loading chart…
Recent News
Artiva Biotherapeutics Insider Sold Shares Worth $255,746, According to a Recent SEC Filing
MT Newswires · Sep 9, 2026 8:09 PM
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
GlobeNewswire · Sep 8, 2026 11:30 AM
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
GlobeNewswire · Sep 2, 2026 12:30 PM
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 6, 2026 8:05 PM
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Jul 17, 2026 11:30 AM
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?
Zacks · Jul 8, 2026 1:40 PM
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
GlobeNewswire · Jun 23, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ARTV's money flow as a full page
Social Sentiment
Avg +0.70 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.